Alpha Tau Medical (DRTS) rings the bell at NASDAQ Apr. 11, 2022

What a thrill to be with friends and colleagues at NASDAQ!

Congratulations to the entire Alpha Tau Medical team on its remarkable success in bringing hope and healing to patients with solid tumor cancers thought to be uncurable.

We at HekaBio K.K. are extremely grateful to be an early partner and investor in Alpha Tau. It’s our mission to keep advancing this technology in Japan.